Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
The Future of Pharma Partnerships: Strategic Alliances Driving Innovation
Beyond the Signing Ceremony Why Alliances Became the Industrys Growth EngineThere is a familiar photograph in pharmaceutical strategy two chief executives a signed term sheet a market capitalization moving
Next-Generation Fill-Finish Technologies for Sterile Drug Products
American pharmaceutical companies have spent a decade optimizing discovery clinical operations and commercial launch The step that actually puts a sterile product into a container has received a fraction of that attention and it is now the step most likely to determine whether a launch lands on sche...
Digital Transformation and Innovation in the U.S. Pharmaceutical Industry
Something fundamental has shifted inside American pharmaceutical companies over the past few years The clipboards are gone The manual logbooks have been replaced by sensors dashboards and predictive alerts that flag problems before they happen This shift didnt occur overnight but it has accelerated...
Mass Spectrometers: Principles, Instrumentation, Applications, and Future Perspectives
Mass spectrometry MS is one of the most powerful analytical technologies available in modern science It enables the identification characterization and quantification of compounds based on their masstocharge ratio mz Since its development in the early twentieth century mass spectrometry has evolved...
Beyond the Chiral Blind Spot: Agentic AI and the Future of Stereochemistry-Aware Drug Discovery
Artificial intelligence AI is rapidly changing pharmaceutical research From target identification and literature analysis to molecular design and biological prediction AI is becoming an increasingly important research partner Generative AI has accelerated molecular ideation and expanded the chemical...
U.S. Pharmaceutical Business Strategy: FDA Regulation, Innovation, Outsourcing and Market Growth
The American pharmaceutical industry sits at a strange crossroads right now On one hand its never been more scientifically capable cell and gene therapies mRNA platforms and AIassisted drug discovery are turning impossible diseases into treatable ones On the other hand its never been harder to run...
Precision Medicine Commercialization: Strategic Pathways to Global Market Access
Precision medicine has won the scientific argument More than sixty percent of new cancer drugs approved in recent years have been targeted therapies dependent on a companion diagnostic to identify the patients who should receive them and the model is now spreading beyond oncology into neurology immu...
Global Clinical Trial Strategies: Navigating Regulatory Complexity and Operational Excellence
US biopharmaceutical companies have spent two decades treating global trial expansion as an arithmetic problem more countries more sites more patients faster enrollment lower cost per subject That arithmetic no longer holds Between the start of and the start of essentially every regulatory jurisdi...
Future of Pharma IT Infrastructure: Building Agile, Secure, and Data-Driven Enterprises
For twenty years pharmaceutical IT was budgeted as overhead It kept the email running the ERP patched and the auditors satisfied and it was measured on uptime and unit cost That framing is now obsolete in the United States and the evidence arrived in from three different directions at once
R&D Strategies for First-in-Class and Best-in-Class Therapeutics
Ask a US pharmaceutical executive whether their company pursues firstinclass or bestinclass assets and the answer is almost always both Ask how the portfolio is governed resourced and measured and the answer is almost always as though there were only one kind of program The same stage gates the same...
